Category: Health & Medicines > Health Care Supplement > Dolutegravir
Country/Region: China State/Province: Hubei
Main Products: Steriods, Pharmaceutical Chemicals
Business Type: Supplier, Buying House
Year Established: 2006
Employees: 201 - 300 People
Plant Area: 50,000-100,000 square meters
Main Markets: South America 11% Africa 12% Eastern Asia 8% Domestic Market 12% North America 10% Eastern Europe 11% Southern Europe 8% Mid East 9% Northern Europe 10% Oceania 9%
Trade Capacity: FOB, EXW, Express Delivery
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Wuhan
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: confidential
Export Revenue: US$2.5 Million - US$5 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 71% - 80%
Payment Modes: USD, AUD, CHF
Lead Time: 11 days
Import/Export Mode: Using an agent